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Abstract
Background: Cardiovascular diseases represent an increasing share of the global disease burden. There is concern
that increased consumption of palm oil could exacerbate mortality from ischemic heart disease (IHD) and stroke,
particularly in developing countries where it represents a major nutritional source of saturated fat.
Methods: The study analyzed country-level data from 1980-1997 derived from the World Health Organization’s
Mortality Database, U.S. Department of Agriculture international estimates, and the World Bank (234 annual
observations; 23 countries). Outcomes included mortality from IHD and stroke for adults aged 50 and older.
Predictors included per-capita consumption of palm oil and cigarettes and per-capita Gross Domestic Product as
well as time trends and an interaction between palm oil consumption and country economic development level.
Analyses examined changes in country-level outcomes over time employing linear panel regressions with country-
level fixed effects, population weighting, and robust standard errors clustered by country. Sensitivity analyses
included further adjustment for other major dietary sources of saturated fat.
Results: In developing countries, for every additional kilogram of palm oil consumed per-capita annually, IHD
mortality rates increased by 68 deaths per 100,000 (95% CI [21-115]), whereas, in similar settings, stroke mortality
rates increased by 19 deaths per 100,000 (95% CI [-12-49]) but were not significant. For historically high-income
countries, changes in IHD and stroke mortality rates from palm oil consumption were smaller (IHD: 17 deaths per
100,000 (95% CI [5.3-29]); stroke: 5.1 deaths per 100,000 (95% CI [-1.2-11.0])). Inclusion of other major saturated fat
sources including beef, pork, chicken, coconut oil, milk cheese, and butter did not substantially change the
differentially higher relationship between palm oil and IHD mortality in developing countries.
Conclusions: Increased palm oil consumption is related to higher IHD mortality rates in developing countries.
Palm oil consumption represents a saturated fat source relevant for policies aimed at reducing cardiovascular
disease burdens.
Background
The production and human consumption of palm oil, a
tropical vegetable oil rich in saturated fats, have risen
substantially in recent years, increasing by 40% from
1990 to 2007 in the world’sl e a s td e v e l o p e dc o u n t r i e s
[1]. While palm oil production has been used as a tool
for economic development in Southeast Asia, contro-
versy has flared over the deleterious environmental
effects of its production and the potential that increased
consumption damages population health [2,3].
Experts believe that the saturated fat in palm oil wor-
sens cardiovascular health outcomes [2,4]. Experimental
evidence confirms that consumption of palm oil
increases plasma concentrations of total cholesterol and
low-density lipoproteins (LDLs) compared to other
more unsaturated vegetable oils [5-7]. Increases in total
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the risk of ischemic heart disease (IHD) [8-12], and ran-
domized controlled trials have clearly shown that repla-
cement of the saturated fats present in usual diets with
polyunsaturated fats reduces IHD rates [13]. In Poland,
substitution away from saturated fats towards non-
hydrogenated rapeseed and soya bean oil was associated
with a steep and rapid decline in coronary heart disease
mortality between 1990 and 2002, even after adjusting
for changes in smoking and fruit and vegetable intake
[14,15]. Therefore, although none of these trials consider
palm oil explicitly, we hypothesize that increased palm
oil consumption, like that observed in many developing
countries, raises the risk of IHD. Consistent with this,
after per-capita consumption of palm oil increased in
Mauritius during a decade of economic growth, a gov-
ernment-led intervention to decrease palm oil use was
followed by a substantial drop in mean plasma choles-
terol levels [16]. Thus, we believe that potential reduc-
tions in cardiovascular mortality are likely related to
reductions in palm oil consumption, increasing use of
healthier, culturally-acceptable, affordable and available
substitute oils, and other changes in the epidemiologic
environment (e.g., reductions in smoking).
Ischemic heart disease and cerebrovascular disease –
principally stroke – are conditions of particular concern
for developing countries. With rising household
incomes, urbanization, and some success against child
mortality, the burden of chronic diseases has increased
sharply. In developing countries, health systems long
o r i e n t e dt o w a r d si n f e c t i o u sd i s e a s e sn o wf a c et h ec h a l -
lenge of addressing persistent infectious diseases as well
as rising chronic disease burdens [4,17,18]. In balancing
development, environmental, and health concerns, it is
necessary to consider the contribution of increased palm
oil consumption to the growing burdens of IHD and
stroke in the developing world [4,16-19], particularly in
view of both the rapidity and magnitude of the change
in IHD mortality in middle-income countries that have
decreased their intake of palm oil [16] or butterfat
[14,15].
Methods
Overview
This study evaluates how palm oil consumption impacts
cardiovascular disease mortality rates due to ischemic
heart disease (IHD) and stroke. It uses panel data from
multiple countries, adjusting for risk factors that have
previously been shown to contribute to IHD and stroke
deaths. The study covers the period between 1980 and
1997. Each observation describes one year in one coun-
try based on data from four publicly available sources
that provide information on mortality by cause, domes-
tic consumption of palm oil, domestic consumption of
manufactured cigarette products, and other economic,
demographic, and nutrition indicators.
Data
The World Health Organization’s( W H O )M o r t a l i t y
Database provides, for each country and year, the num-
bers of registered deaths for people age ≥ 50 years with
underlying causes in two cardiovascular disease (CVD)
categories: ischemic heart disease and cerebrovascular
disease as coded by the International Classification of
Diseases system [20]. Additionally, it provides the popu-
lation size by country and by year of individuals age ≥
50 years used to calculate the rates of deaths due to
each of the two cardiovascular disease categories. The
U.S. Department of Agriculture (USDA) compiles inter-
national data on country-level annual total domestic
consumption of palm oil for food use [21]. Additionally,
it provides information on the annual total domestic
consumption of manufactured cigarette products and on
domestic food consumption of other major sources of
dietary saturated fat: specifically, beef, pork, chicken,
coconut oil, milk, eggs and cheese [21]. The World
Bank’s World Development Indicators (WDI) database
provides information on measures of economic develop-
ment [22]. These measures include per-capita Gross
Domestic Product (GDP) expressed in constant 2005
international dollars and country income status (i.e.,
countries defined as “High-Income Countries” are those
ranked in the top 30 nations in terms of per-capita GDP
since the 1970s; countries defined as “Developing Coun-
tries” are those that have increased their per-capita GDP
substantially over this period). The WDI also provides
the total population of a country in a given year. All
countries in the world were potentially eligible for inclu-
sion in this study’s analyses. The only inclusion criterion
was that a country must have information on all vari-
ables available for at least some years during the period
1980-1997. In the main analyses, there are 234 complete
country-year observations from 23 countries. Inclusion
of additional covariates in sensitivity analyses reduces
the number of country-year observations.
Model
In the context of economic development, we assess the
impact of dietary consumption of palm oil on deaths
due to two cardiovascular diseases (IHD and stroke) at
the population level, using country-level panel regres-
sion analyses. Specifically, we hypothesize that greater
palm oil consumption will have negative impacts on
population health by increasing cardiovascular disease
burdens and mortality of individuals traditionally con-
sidered at higher risk for these diseases (those aged 50
and above). Furthermore, we hypothesize that palm oil
consumption will be more detrimental in countries
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those countries that have been high-income for longer
p e r i o d so ft i m e .T h eb a s i sf o rt h i sh y p o t h e s i si st h a t
increases in palm oil consumption represent an impor-
tant increase in exposure to saturated fat for the popula-
tions of developing countries, relative to high-income
countries that have consumed greater quantities of satu-
rated fats for longer periods of time, with fewer fluctua-
tions, and with a major proportion of their saturated fat
consumption derived from animal sources. Additionally,
health care systems in developing countries are likely
less oriented towards chronic diseases care in the study
period (1980-1997), a pattern which can lead to greater
mortality risk for those with cardiovascular disease even
for those receiving medical care in these systems.
The main outcomes are mortality rates due to IHD
and stroke, computed as the number of deaths among
adults aged ≥ 50 from these causes divided by the total
population aged ≥ 50 in a given country and year
(deaths per 100,000 persons per year). The main predic-
tors used are per-capita palm oil consumption and the
interaction between the level of palm oil consumption
and a country’s economic development status (i.e.,
developing countries and historically high income coun-
tries; See Table 1).
As other factors also impact cardiovascular disease
mortality, we adjust for these when assessing the rela-
tionship between cardiovascular disease mortality, palm
oil consumption, and development. Cigarette smoking is
a major risk factor for cardiovascular disease incidence
and mortality. We included per-capita consumption of
cigarettes, expressed as pieces (i.e., cigarettes) consumed
each year per-capita. To account for differential health-
care quality and usage patterns by patients which impact
both incidence and mortalityf r o mC V D s ,w ea d j u s tf o r
per-capita GDP as a proxy for health system quality and
coverage [23,24]. Per-capita GDP also acts as a proxy
for differences in calorie consumption and nutrition
over time. Specifically, we include the log of per-capita
GDP in the regression model. Finally, as there are tem-
poral shifts in the burden of CVDs, we include indica-
tors for the 1980s to account for other secular trends
relative to the 1990s.
Sensitivity Analyses
Just as consumption of palm oil has changed over the
period analyzed, so too have other sources of saturated
fat, which could impact the estimated relationship
between palm oil and cause-specific mortality. Using the
international consumption data compiled by the USDA
[21], sensitivity analyses included per-capita consump-
tion of beef, pork, chicken, coconut oil, milk, butter, and
cheese. These sources of saturated fat were not included
in the main analysis because missing data from their
simultaneous inclusion caused too great a loss of sample
size. Instead, each saturated fat source was included as
an additional covariate to the regression in the main
analysis. These sensitivity analyses address the question:
Does the estimated relationship between palm oil, a
country’s level of development and cardiovascular mor-
tality rates attenuate substantially when time-varying
consumption of other saturated fats is included? To
examine potential collinearity between rises in per-
capita palm oil consumption and other sources of diet-
ary saturated fat over time, we regressed per-capita
palm oil consumption on these other sources and on
per-capita GDP using univariate panel regressions with
country fixed effects and robust standard errors.
As the main analysis concerned the potentially differ-
ential effect of palm oil consumption in developing
countries for whom data were available (Table 1), we
assessed whether results were primarily driven by any
single country. We repeated the main analysis, estimat-
ing the same model but dropping each developing coun-
try in turn. We compared these results to those of the
main analysis itself.
Statistical Analyses
We use ordinary least squares panel regressions with
country-level fixed effects examining changes in coun-
try-level outcomes over time. Because the main out-
comes in the models are population averages, we avoid
over-representing small nations and under-representing
large nations by using inverse variance weights for each
country, weighting by a country’sa v e r a g ep o p u l a t i o n
during the study period. This model specification con-
siders historical variations in palm oil consumption
Table 1 Countries Included in the Analysis by Income Status
Historically High-Income Countries
Australia, Canada, Finland, France, Hong Kong, Italy, New Zealand, Netherlands, Norway, Singapore, Spain, Sweden, United States
Developing Countries
Brazil, Colombia, Ecuador, Egypt, Greece, Mexico, Peru, Russia, Thailand, Venezuela
Data: World Bank World Development Indicators. “High-Income Countries” are those countries which have, with rare exception, always ranked in the top 30
nations in terms of per capita GDP since the 1970s.
Unlike other countries included in the analysis, Hong Kong’s official status is different and has changed over time. However, its economic and administrative
organization functioned in ways largely similar to an independent country for the vast majority of the analysis period.
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mitigate potential sources of time-invariant endogeneity
and selection biases that may arise when assessing the
mortality effects of palm oil consumption cross-section-
ally [25]. All analyses were undertaken using Stata 11
(StataCorp, College Station, Texas, USA).
Role of Funding Source
The funding sources for this study had no role in the
study design; collection, analysis, or interpretation of
data; in writing the report; or in the decision to submit
the paper for publication. The corresponding author
had full access to all data in the study and final respon-
sibility for the decision to submit it for publication.
Results
Palm oil consumption in developing countries has a sig-
nificant link to increases in mortality rates for indivi-
duals age 50 and above due to ischemic heart disease
but not due to stroke, with impacts on health above and
beyond those observed in historically high-income coun-
tries. Regressions were used to analyze combined yearly
data on 10 developing countries and 13 historically
high-income countries available from 1980-1997 (Table
1). Compared to historically high-income countries, on
average, developing countries had lower mortality rates
due to ischemic heart disease (Figure 1, Panel A) and
stroke (Figure 1, Panel B) in the 1980s, though these
rates increased more rapidly in developing countries,
resulting in higher mortality rates from both IHD and
stroke in developing countries by the end of the study
period. Over this period, developing countries also had
significantly lower average annual per-capita consump-
tion of cigarettes and major sources of saturated fat
compared to high-income countries with the exception
of palm oil and coconut oil and cigarettes compared to
high-income countries (Table 2), though they experi-
enced greater growth in their palm-oil consumption
than did high-income countries (Figure 2).
Palm oil consumption in developing countries incurs
greater negative health effects than in historically high-
income countries, even after adjustment for other major
risk factors for deaths from IHD and stroke, including
cigarette consumption, economic growth, and secular
trends over time. In developing countries, for every
additional kilogram of palm oil consumed annually per
c a p i t a ,t h eI H Dm o r t a l i t yr a t ei n c r e a s e db y6 8d e a t h s
per 100,000 (95% CI [21-115]); and the mortality rate
for stroke increased by 19 deaths per 100,000 (95% CI
[-12-49]), but the increase in stroke deaths was not sta-
tistically significant (Table 3). For high-income coun-
tries, changes in the mortality rates of both IHD and
stroke deaths with every additional kilogram of palm oil
consumed annually per-capita are substantially smaller
for both IHD and stroke and not significant for stroke
at 17 deaths per 100,000 (95% CI [5.3-28]) and 5.1
deaths per 100,000 (95% CI [-1.2-11]), respectively
(Table 3). The significant and larger increases in IHD
deaths due to palm oil consumption and lack of a simi-
lar significant effect for stroke are consistent with the
underlying causes of IHD and stroke, respectively, as
IHD is primarily due to atherosclerosis, a process influ-
e n c e ds t r o n g l yb yp l a s m ac holesterol and LDL levels
[4,12,13]. However, many strokes are of hemorrhagic
origin with a major causal antecedent being hyperten-
sion. Palm oil and other saturated fats have not been
shown to increase blood pressure, and therefore should
have a weaker link to stroke deaths.
Higher cigarette consumption also increases the pro-
portion of deaths from cardiovascular disease. In the
analysis, for each additional cigarette per-capita smoked
per year, there are an estimated additional 0.05 IHD
deaths per 100,000 (95% CI [-0.15-0.25]), though for
stroke, the estimate is -0.08 deaths per 100,000 (95% CI
[-0.19-0.02]). Just as with palm oil consumption, smok-
ing’s stronger impact, while not significant, appears to
Figure 1 Trends in Mortality Rates from Ischemic Heart Disease
and Stroke in Developing and Historically High-Income
Countries. The figure shows the temporal trends in average
ischemic heart disease (IHD) mortality rates (Panel A) and stroke
mortality rates (Panel B) disaggregated by country economic
development status.
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strong connection in developed countries between cigar-
ette smoking and IHD, but with a neutral to slightly
negative correlation with hypertension [26,27].
Analyses examined whether estimates of palm oil con-
sumption’s link to differentially higher IHD mortality in
developing countries could be explained by simulta-
neous increases in consumption of other major sources
of saturated fat. When per-capita consumption of beef,
coconut oil, milk, pork, or chicken were each individu-
ally included in the regression, despite a loss of sample
size (n between 153 and 217 country-years), the esti-
mated effect of palm oil in these countries remained sig-
nificant at or above 55 deaths per 100,000 (Table 4). For
butter or cheese, where substantial sample size was lost
(n = 177 country-years), the effect of palm oil consump-
tion on IHD mortality lost significance, but its estimated
effect remained in the same range (58 to 66 IHD deaths
per 100,000 range). Per-capita palm oil consumption
itself was significantly related to greater per-capita con-
sumption of pork and to higher per-capita GDP but not
to other major sources of dietary saturated fat intake
(Table 5).
In addition to adjusting for country size, we ensured
that no single growing economy country overly influ-
enced the results by removing each of these 10 growing
economy countries individually and performing the ana-
lysis 10 times. All results are substantially similar to the
main analysis described above. The estimated effect of
palm oil consumption on IHD-specific mortality rates
and the differentially higher effect of palm oil consump-
tion in developing countries were stable across
Table 2 Descriptive Statistics
Developing
Countries
Historically High-Income
Countries
Difference** (Developing - High-
Income)
Mean Std. Dev. Mean Std. Dev.
N = 166 N = 244
IHD mortality rate (per 100,000)* 753 624 1,144 512 -392
Stroke mortality rate (per 100,000)* 413 307 723 307 -310
Per-capita palm oil consumption (kg) 3.5 5.1 4.3 8.2 -0.8
Per-capita tobacco consumption (pieces) 1,052 857 1,398 687 -345
Per-capita coconut oil consumption (kg) 1.4 1.4 1.3 1.3 0.1
Per-capita beef consumption (kg) 19 8.9 24 13 -4.9
Per-capita milk consumption (kg) 86 59 104 39 -18
Per-capita butter consumption (kg) 3.5 4.1 4.5 3.6 -1.0
Per-capita cheese consumption (kg) 3.8 4.4 9.1 4.9 -5.3
Per-capita pork consumption (kg) 17.2 14 30 11.4 -13
Per-capita chicken consumption (kg) 9.5 4.7 18 9.5 -8.0
Per-capita GDP (2005 international $)*** 7,914 3,927 23,081 5,230 -15,167
Data: USDA statistics on country-specific consumption of agricultural commodities (domestic dietary palm oil consumption, domestic consumption of
manufactured tobacco products, domestic consumption of other major sources of saturated fat); WHO Mortality Database; World Bank’s World Development
Indicators, 1980-1997.
* Mortality rates for IHD and stroke are calculated for each country/jurisdiction’s population of individuals aged 50 years and older.
** All differences significant (t-test) at p < 0.05 except per-capita palm oil consumption and per-capita coconut oil consumption
*** Per-capita GDP calculated using purchasing power parity (PPP)
We report the number of observations (N) at the country-year level.
There are 10 “developing economies” (countries that have grown in wealth since the 1970s) and 13 “high-income countries” (countries that have been
historically wealthy since the 1970s) in the data set.
Figure 2 Changes in Annual Per-Capita Palm Oil Consumption.
The figure shows the mean and interquartile range of increases in
per-capita palm oil consumption for developing countries and for
historically-high income countries.
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developing countries was attenuated by the removal of
Colombia, Egypt, or Thailand (Table 6).
Discussion
In developing countries, increases in palm oil consump-
tion are associated with higher mortality due to
ischemic heart disease (IHD) to a greater degree than in
countries that have been historically wealthy. These
increases occur above and beyond those caused by
smoking and other important economic, demographic,
and nutritional trends.
Global palm oil consumption represents an important
health policy challenge. The consumption of palm oil
overtook soybean oil consumption globally in 2003, and
the increasing price competitiveness of palm oil relative
to soybean oil has resulted in palm oil’s status as the
dominant oil on the global market [28]. The world mar-
ket for palm oil is forecast to surpass 100 million metric
tons by 2015, fueled primarily by demand in growing
economies such as China and India [29]. Their future
palm oil consumption could potentially increase cardio-
vascular disease-specific mortality.
National and international organizations should con-
sider health as part of their evaluations of the potential
benefits and harms of palm oil production and con-
sumption, weighing these against relevant alternatives in
light of a growing body of evidence regarding the dis-
proportionate health harms of saturated fat in the con-
text of rapidly developing countries. Currently, the
World Bank’s Draft Framework for Engagement in the
Palm Oil Sector cites “poverty reduction” as a key ratio-
nale for supporting palm oil production, citing “negative
environmental and social impacts” but not health con-
cerns as potential drawbacks of the strategy [30]. The
case of palm oil represents a more general problem that
programs focused on economic development and those
focused on health are often siloed. As part of the discus-
sion around the United Nation’s High-level Meeting on
Non-communicable Disease Prevention and Control in
September 2011, recent calls have included the develop-
ment of “healthy crops” and policies that encourage
their sustainability [31] and the deeper involvement of
the World Health Organization in food and agricultural
production to support these efforts [32].
Policies that curtail palm oil consumption in rapidly
developing countries require careful consideration. One
policy now in use to lower CVD risk in developed coun-
tries has been to reduce the use of hydrogenated oils,
which contain the trans-fats that raise LDL in a similar
manner to that of saturated fats. However, in many
countries, this has led to substitution of palm oil for
trans-fats, which may undermine the health goals of
these efforts. Nutritional and environmental concerns
associated with palm oil production and consumption
may prompt a call for measures to increase the relative
price of palm oil. Benefits of such a policy must be
weighed against what fat substitutes would be made,
especially by poorer individuals, if the prices of both
trans-fats and saturated fats were targeted via tax
policies.
Our findings are consistent with the extensive litera-
ture documenting the link between the consumption of
saturated fats (such as palm and coconut oil, as well as
animal fats) on plasma total cholesterol and LDL choles-
terol and ischemic heart disease [2,4-6,8-13]. National
and international organizations including the World
Health Organization and U.S. Departments of Agricul-
ture and of Health and Human Services recommend
consuming fewer saturated fats as opposed to monoun-
saturated or polyunsaturated fats to reduce the preva-
lence of cardiovascular diseases [33,34].
Our findings are also consistent with the previous
results that show that high serum LDL levels cause pre-
dominantly IHD and some strokes through blockage
(thrombosis) in vessels narrowed by atherosclerosis,
whereas LDL has no important relationship to hyperten-
sion, which can lead to many strokes from hemorrhages
of the cerebral blood vessels. Therefore, our finding of a
weaker relationship between palm oil and stroke than
Table 3 Palm Oil Consumption and IHD and Stroke Mortality Rates
IHD Mortality Rate (per 100,000
adults age ≥ 50 years)
Stroke Mortality Rate (per 100,000
adults age ≥ 50 years)
Palm oil consumption (kg per-capita) 17.0 [5 - 29] 5.1 [-1.2 - 11]
Additional effect of palm oil in developing countries (kg per-capita) 51 [3.9 - 98] 13 [-18 - 45]
Cigarette consumption (pieces per-capita) 0.05 [-0.15 - 0.25] -0.08 [-0.19 - 0.02]
Log per-capita GDP (%) -2,132 [-3,130 - -1,133] -930 [-1,307 - -552]
1980s (compared to 1990s) -166 [-349 - 17] -70 [-135 - -4.1]
R-squared 0.58 0.54
Observations (country-years) 234 234
Number of countries 23 23
Regressions use robust standard errors clustered by country
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levels.
The relationship between increased palm oil consump-
tion in developing countries and IHD mortality is con-
sonant with the previously mentioned link between
saturated fat consumption and IHD mortality. The
weaker relationship between palm oil consumption and
IHD mortality in historically high-income countries
could be due to a variety of reasons. In many historically
high-income countries screening for cardiovascular dis-
eases is more common, the use of drugs such as statins
for both primary and secondary prevention is more
widespread, and, in general, the quality of hospital care
and availability of advanced lifesaving technologies may
be better. Additionally, in many historically high-income
countries, the proportion of diets that comes from
Table 4 The Relationship between Palm Oil Consumption and IHD Mortality Rates in High Income and Developing
Countries Remains Unchanged when Adjusting for Other Sources of Dietary Saturated Fat
Dependent variable in all
regressions: IHD mortality
Adjusting for
Beef
Consumption
Adjusting for
Coconut Oil
Consumption
Adjusting for
Milk
Consumption
Adjusting for
Butter
Consumption
Adjusting for
Cheese
Consumption
Adjusting for
Pork
Consumption
Adjusting for
Chicken
Consumption
Palm oil consumption (kg
per-capita)
18.9 3.3 -3.4 -1.2 1.7 19 19
[7.7 - 30] [-1.4 - 7.9] [-39 - 32] [-43 - 41] [-40 - 43] [8.0 - 30] [8.4 - 30]
Additional effect of palm oil
in developing countries (kg
per-capita)
52 149 70 59 65 41 72
[26 - 78] [93 - 205] [19 - 120] [-58 - 175] [-58 - 188] [10 - 72] [18 - 126]
Cigarette consumption
(pieces per-capita)
-0.00 0.26 0.01 0.05 0.07 -0.03 0.11
[-0.29 - 0.29] [0.15 - 0.37] [-0.18 - 0.21] [-0.20 - 0.29] [-0.15 - 0.28] [-0.23 - 0.18] [-0.26 - 0.48]
Log per-capita GDP (%) -2,259 -728 -2,262 -2,116 -2,469 -2,370 -2,191
[-3,201 -
-1,317]
[-1,061 - -395] [-2,830 -
-1,695]
[-2,851 -
-1,381]
[-3,160 - -1,779] [-3,271 -
-1,469]
[-3,002 - -1,381]
1980s (compared to 1990s) -176 6.7 -171 -133 -152 -162 -154
[-348 - -4.7] [-68 - 82] [-341 - -1.2] [-304 - 38] [-328 - 23] [-353 - 28] [-425 - 118]
Beef consumption (kg per-
capita)
6.6
[-17 - 30]
Coconut oil consumption
(kg per-capita)
21
[-35 - 77]
Milk consumption (kg per-
capita)
4.8
[-0.7 - 10]
Butter consumption (kg
per-capita)
-50
[-119 - 19]
Cheese consumption (kg
per-capita)
32
[-15 - 79]
Pork consumption (kg per-
capita)
9.6
[-10 - 29]
Chicken consumption (kg
per-capita)
6.3
[-30 - 43]
Constant 23,221 7,942 23,066 22,180 25,213 24,411 22,299
[13,631 -
32,811]
[4,505 - 11,379] [17,424 -
28,708]
[14,900 -
29,460]
[18,243 -
32,183]
[15,454 -
33,368]
[13,483 -
31,115]
Observations 217 153 181 177 177 209 202
R-squared 0.60 0.89 0.70 0.64 0.64 0.61 0.59
Number of countries 22 13 20 19 19 21 20
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increases in CVD deaths from increased palm oil con-
sumption in historically high-income countries may be
due to the fact that at baseline palm oil consumption
levels were already relatively high and saturated fats
from animal products remained the major sources of
saturated fat for most people’s diets.
There are several limitations to this study. First, major
palm oil producing and consuming countries including
Indonesia and Malaysia were not represented in the pre-
sent analysis because complete data on other character-
istics including cause-specific mortality and cigarette
consumption were not available for the time period con-
sidered. The relationship of palm oil consumption and
health in these settings is of great interest and should be
explored when such data become available. Second,
cigarette consumption per-capita does not have a statis-
tically significant relationship with cardiovascular mor-
tality outcomes in our analysis. This could potentially be
due to collinearity with other variables in the regression.
Of note, cigarette smoking is expressed as additional
pieces (e.g., cigarettes) consumed per-capita each year.
While pack consumption or pack-days are often used,
the quantity of cigarettes in a pack changed within
countries and over time in our multi-country analysis
prompting us to report outcomes in per-cigarette terms
to avoid potential confusion as to the definition of packs
when the results are interpreted. For example, a com-
mon pack size in Australia is 25 although 20-40 cigar-
ette packs are sold. In Canada, it is 20-25, and in
Malaysia, a pack can have as few as 14 cigarettes. In
fact, in some developing countries, stores often sell indi-
vidual cigarettes. Third, the use of country-level data in
this ecologic study may mask individual variability in
the consumption of palm oil and its real impact on
health. Importantly, our study employs an econometric
model that does not explicitly adjust for all factors that
affect CVD deaths. However, by employing country
fixed effects that control for time-invariant confounders
we partially address omitted variable bias. Our regres-
sion results may have a causal interpretation if we
assume that unaccounted IHD and stroke risk factors
Table 5 Univariate Relationships of Palm Oil Consumption and Other Sources of Dietary Saturated Fat and Per-capita
GDP
Palm oil consumption (kg per-capita) P-value 95% Confidence Interval
Per-capita coconut oil consumption (kg) -1.58 0.09 [-3.44 - 0.28]
Per-capita beef consumption (kg) -0.06 0.42 [-0.19 - 0.08]
Per-capita milk consumption (kg) 0.00 0.66 [-0.01 - 0.01]
Per-capita butter consumption (kg) 0.02 0.77 [-0.13 - 0.18]
Per-capita cheese consumption (kg) 0.14 0.44 [-0.22 - 0.50]
Per-capita pork consumption (kg) 0.08 0.002 [0.03 - 0.13]
Per-capita chicken consumption (kg) 0.03 0.70 [-0.13 - 0.19]
Per-capita GDP (2005 international $)* 8.61 0.01 [2.01 - 15.20]
* Per-capita GDP is logged transformed so the coefficient can be interpreted as increases in per-capita consumption of palm oil for each percent increase in per-
capita GDP.
Table 6 Sensitivity Analysis: Impact of Palm Oil Consumption on IHD Mortality, with Growing Economies Removed
One at a Time
Dependent variable:
IHD mortality
Removed
Brazil
Removed
Colombia
Removed
Ecuador
Removed
Egypt
Removed
Greece
Removed
Mexico
Removed
Peru
Removed
Russia
Removed
Thailand
Removed
Venezuela
Palm oil consumption
(kg per-capita)
16 17 17 18 17 18 17 5 17 17
95% CI [4.5 - 28] [5.1 - 29] [5.6 - 29] [6.1 - 29] [5.2 - 29] [6.2 - 29] [5.5 - 29] [-3.9 - 14] [6.0 - 29] [5.4 - 29]
Additional effect of
palm oil in
developing country
(kg per-capita)
50 50 69 46 51 52 51 63 38 49
95% CI [3.5 - 97] [-62 - 161] [23 - 116] [-7.7 - 99] [3.5 - 98] [3.4 - 100] [4.3 - 99] [28 - 99] [-3.8 - 80] [1.0 - 96]
Observations
(country-years)
225 227 226 231 229 223 230 225 226 228
R-squared 0.65 0.58 0.59 0.59 0.58 0.59 0.58 0.45 0.59 0.58
Number of countries 22 22 22 22 22 22 22 22 22 22
Robust standard errors clustered by country. Econometric specification is identical to that of Table 3. Regression analysis was performed eleven times, with a
single developing country (listed in the table heading) removed from the sample to test whether any one country was pivotal in the results reported in Table 3.
For clarity of exposition, however, only the coefficient of interest is presented.
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study period and no selection biases exist. We also
make no cross-sectional comparisons, avoiding selection
issues associated with non-randomized samples. How-
ever, if palm oil consumption is correlated with other
time-varying IHD and stroke risk factors then our analy-
sis cannot separately disentangle the causal impact of
palm oil consumption on IHD and stroke from the
effects of these other factors. Despite our adjustment for
cigarette use and per-capita GDP, the possibility of
other unmeasured changes contributing to the effect is
real as developing countries have seen nutritional transi-
tions that include increased obesity rates. Our sensitivity
analyses suggest that the effect we have estimated for
IHD in developing countries is fairly robust with respect
to changing patterns of consumption of other major
sources of saturated fat, though other factors not
included may still play an important role. Nonetheless,
ecological estimates that are consistent with smaller ran-
domized trials examining intermediate outcomes and
known biological mechanisms contribute significantly to
the evidence on important issues like the link between
palm oil consumption and CVD mortality.
Conclusions
This study is the first to document a significant relation-
ship between increased palm oil consumption and
higher IHD mortality rates at a population level in mul-
tiple countries. As the evidence base linking palm oil
consumption and population health grows, decision
makers should consider policies that focus on consump-
tion of both plant and animal sources of saturated fat to
address rapidly rising ischemic heart disease mortality in
developing countries.
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